Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer

Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer

Ru Chen,1,2,&ast; Ming Jiang,1,&ast; Bing Hu,1 Bin Fu,1 Ting Sun1 1Department of Urology, the First Affiliated Hospital of Nanchang University, Nanchang City, People’s Republic of China; 2Department of Urology, the First Hospital of Putian City, Putian City, People’s Republic of China&as...

Full description

Bibliographic Details
Main Authors:	Chen R, Jiang M, Hu B, Fu B, Sun T
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-02-01
Series:	International Journal of General Medicine
Subjects:	bladder cancer plods immune infiltration prognosis biomarker
Online Access:	https://www.dovepress.com/comprehensive-analysis-of-the-expression-prognosis-and-biological-si-2-peer-reviewed-fulltext-article-IJGM

Similar Items

Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer
by: Zhang J, et al.
Published: (2022-03-01)

Clinical Prognostic Value of the PLOD Gene Family in Lung Adenocarcinoma
by: Yiming Meng, et al.
Published: (2022-02-01)

The relationship between PLOD1 expression level and glioma prognosis investigated using public databases
by: Lei Tian, et al.
Published: (2021-05-01)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
by: Bo Yang, et al.
Published: (2020-09-01)

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2
by: Qiqi Xu, et al.
Published: (2022-05-01)

Integrated Profiling Identifies PLOD3 as a Potential Prognostic and Immunotherapy Relevant Biomarker in Colorectal Cancer
by: Junhong Shi, et al.
Published: (2021-09-01)

PLOD Family: A Novel Biomarker for Prognosis and Personalized Treatment in Soft Tissue Sarcoma
by: Siming Gong, et al.
Published: (2022-04-01)

A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3)
by: Siming Gong, et al.
Published: (2021-09-01)

PLOD2 high expression associates with immune infiltration and facilitates cancer progression in osteosarcoma
by: Zhen Wang, et al.
Published: (2022-10-01)

PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma
by: Siming Gong, et al.
Published: (2023-02-01)

PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression
by: Nina Kreße, et al.
Published: (2022-05-01)

Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target
by: Yasutaka Yamada, et al.
Published: (2019-09-01)

Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma
by: Yawei Sun, et al.
Published: (2021-12-01)

Cerebral small vessel disease caused by PLOD3 mutation: Expanding the phenotypic spectrum of lysyl hydroxylase‐3 deficiency
by: Ji Zhou, et al.
Published: (2022-09-01)

PLAUR as a Potential Biomarker Associated with Immune Infiltration in Bladder Urothelial Carcinoma
by: Liu M, et al.
Published: (2021-09-01)

A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
by: Jiao-chen Luan, et al.
Published: (2021-08-01)

Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA
by: Zexi He, et al.
Published: (2022-09-01)

PLOD2, a key factor for MRL MSC metabolism and chondroprotective properties
by: Sarah Bahraoui, et al.
Published: (2024-03-01)

A novel prognostic model based on cellular senescence-related gene signature for bladder cancer
by: Lianmin Luo, et al.
Published: (2022-11-01)

N6-methyladenosine modification of PLOD2 causes spermatocyte damage in rats with varicocele
by: Huan Li, et al.
Published: (2023-09-01)

Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer
by: Lijuan Gao, et al.
Published: (2022-09-01)

MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder
by: Lin Zhu, et al.
Published: (2022-05-01)

The first case report of Kyphoscoliotic Ehlers-Danlos syndrome of chinese origin with a novel PLOD1 gene mutation
by: Xiaolin Ni, et al.
Published: (2020-10-01)

Genetic Analysis and Functional Study of a Pedigree With Bruck Syndrome Caused by PLOD2 Variant
by: Ruo-li Wang, et al.
Published: (2022-05-01)

Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer
by: Xingyu Chen, et al.
Published: (2020-06-01)

PLOD3 facilitated T cell activation in the colorectal tumor microenvironment and liver metastasis by the TNF-α/ NF-κB pathway
by: Min Ding, et al.
Published: (2024-01-01)

Gelsolin, an Actin-Binding Protein: Bioinformatic Analysis and Functional Significance in Urothelial Bladder Carcinoma
by: Abeer A. Alsofyani, et al.
Published: (2023-10-01)

Machine learning-based identification of tumor-infiltrating immune cell-associated model with appealing implications in improving prognosis and immunotherapy response in bladder cancer patients
by: Hualin Chen, et al.
Published: (2023-03-01)

Distribution of the Warmblood Fragile Foal Syndrome Type 1 Mutation (PLOD1 c.2032G>A) in Different Horse Breeds from Europe and the United States
by: Simone Reiter, et al.
Published: (2020-12-01)

Systematical analysis of ferroptosis regulators and identification of GCLM as a tumor promotor and immunological biomarker in bladder cancer
by: Song Wang, et al.
Published: (2022-10-01)

SKA3 is a prognostic biomarker and associated with immune infiltration in bladder cancer
by: Chenyang Wang, et al.
Published: (2022-05-01)

Targeted Demethylation of the PLOD2 mRNA Inhibits the Proliferation and Migration of Renal Cell Carcinoma
by: Congcong Cao, et al.
Published: (2021-06-01)

Hypoxia and TGF-β1 induced PLOD2 expression improve the migration and invasion of cervical cancer cells by promoting epithelial-to-mesenchymal transition (EMT) and focal adhesion formation
by: Feifei Xu, et al.
Published: (2017-05-01)

The Collagen-Modifying Enzyme PLOD2 Is Induced and Required during L1-Mediated Colon Cancer Progression
by: Sanith Cheriyamundath, et al.
Published: (2021-03-01)

EIF4A3 serves as a prognostic and immunosuppressive microenvironment factor and inhibits cell apoptosis in bladder cancer
by: Bing Hu, et al.
Published: (2023-05-01)

Comprehensive Analysis Identifies PKP3 Overexpression in Pancreatic Cancer Related to Unfavorable Prognosis
by: Yan Du, et al.
Published: (2023-09-01)

Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme
by: Yintao Ye, et al.
Published: (2023-01-01)

The prognostic significance and clinical relevance of stem cell characteristic in bladder cancer
by: Xia Chen, et al.
Published: (2024-02-01)

A severe case of PLOD1‐related kyphoscoliotic Ehlers–Danlos syndrome associated with several arterial and venous complications: A case report
by: Malika Foy, et al.
Published: (2023-02-01)

KRAB-Induced Heterochromatin Effectively Silences <i>PLOD2</i> Gene Expression in Somatic Cells and Is Resilient to TGFβ1 Activation
by: Rutger A. F. Gjaltema, et al.
Published: (2020-05-01)